🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
27.32
+0.42 (1.54%)
At close: Nov 19, 2026, 4:00 PM EST
27.03
-0.29 (-1.04%)
Pre-market: Nov 20, 2026, 4:03 AM EST

Nanobiotix Revenue

Nanobiotix had revenue of 5.55M EUR in the half year ending June 30, 2026, a decrease of -40.24%. This brings the company's total for the last twelve months to 11.51M. In the year 2025, Nanobiotix had annual revenue of 32.59M.

Revenue (ttm)
11.51M EUR
Revenue Growth
+13.27%
P/S Ratio
110.05
Revenue / Employee
117,408 EUR
Employees
98
Market Cap
1.45B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202532.59M39.78M-
Dec 31, 2024-7.19M-43.40M-
Dec 31, 202336.21M31.43M658.12%
Dec 31, 20224.78M2.13M80.43%
Dec 31, 20212.65M135.00K5.37%
Dec 31, 20202.51M-29.00K-1.14%
Dec 31, 20192.54M-938.00K-26.96%
Dec 31, 20183.48M-242.53K-6.52%
Dec 31, 20173.72M-1.70M-31.36%
Dec 31, 20165.42M1.41M35.03%
Dec 31, 20154.02M1.24M44.91%
Dec 31, 20142.77M2.59M1,398.23%
Dec 31, 2013184.94K-785.67K-80.95%
Dec 31, 2012970.61K-389.71K-28.65%
Dec 31, 20111.36M225.46K19.87%
Dec 31, 20101.13M-1.63M-59.00%
Dec 31, 20092.77M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Innoviva438.32M
MannKind413.37M
Novavax411.65M
Nuvation Bio201.73M
AnaptysBio60.04M
Intellia Therapeutics52.89M
Ocular Therapeutix50.38M
Generate Biomedicines21.07M
Revenue Rankings